Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: Results of the second human pilot study

Endoscopy

Volumn 40, Issue 5, 2008, Pages 406-413

  Moreno, Christophe ^a   Closset, J ^a   Dugardeyn, S ^a   Barea M ^a   Mehdi, A ^a   Collignon, L ^a   Zalcman, M ^a   Baurain, M ^a   Le Moine, O ^a   Deviere J ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALIZAPRIDE; ANALGESIC AGENT; CHLORHEXIDINE; DICLOFENAC; PARACETAMOL; PROTON PUMP INHIBITOR; TRAMADOL;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DYSPHAGIA; ENDOSCOPIC SURGERY; EPIGASTRIC PAIN; ESOPHAGITIS; FEASIBILITY STUDY; FEMALE; GASTROPLASTY; HUMAN; LONG TERM CARE; MALE; MORBID OBESITY; MULTICENTER STUDY; NAUSEA; NECK PAIN; OUTCOME ASSESSMENT; PATIENT SAFETY; PHLEBITIS; PILOT STUDY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RETREATMENT; SORE THROAT; SURGICAL STAPLING; SURGICAL TECHNIQUE; TRANSORAL GASTROPLASTY; TREATMENT RESPONSE; VOMITING; WEIGHT REDUCTION;

ADULT; ANTI-INFLAMMATORY AGENTS; ENDOSCOPY, DIGESTIVE SYSTEM; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PILOT PROJECTS; SURGICAL STAPLING; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 43849101048     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995748     Document Type: Article

References (28)

1. Haslam DW, James WPT. Obesity. Lancet 2005; 366: 1197-1209
2. DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med 2007; 356: 2176-2183
3. Li Z, Bowerman S, Heber D. Health ramifications of the obesity epidemic. Surg Clin North Am 2005; 85: 681-701
4. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-1110
5. Abu-Abid S, Szold A, Klausner J. Obesity and cancer. J Med 2002; 33: 73-86
6. Engeland A, Bjorge T, Tverdal A et al. Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology 2004; 15: 79-85
7. Wadden TA, Berkowitz RI, Womble LG et al. Randomized trial of life-style modification and pharmacotherapy for obesity. N Engl J Med 2005; 353: 2111-2120
8. James WP, Astrup A, Finer N et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM study group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356: 2119-2125
9. Pi-Sunyer FX, Aronne LJ, Heshmati HM et al, RIO-North America Study group. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 2006; 295: 761-775
10. NIH Technology Assessment Conference Panel. Methods for voluntary weight loss and control. Ann Intern Med 1993; 119: 764-770
11. Sjöström L, Lindroos AK, Peltonen M et al. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693
12. National Institutes of Health.. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the Evidence Report. Obes Res 1998; 6 (Suppl 2): 51S-209S
13. Roa PE, Kaidar-Person O, Pinto D et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg 2006; 16: 1323-1326
14. Himpens J, Dapri G, Cadiere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 2006; 16: 1450-1456
15. Johnston D, Dachtler J, Sue-Ling HM et al. The Magenstrasse and Mill operation for morbid obesity. Obes Surg 2003; 13: 10-16
16. Closset J, Mehdi A, Barea M et al. Results of silastic ring vertical gastroplasty more than 6 years after surgery: analysis of a cohort of 214 patients. Obes Surg 2004; 14: 1233-1236
17. Colquitt J, Clegg A, Loveman E et al. Surgery for morbid obesity. Cochrane Database Syst Rev 2005; 4: CDO03641
18. Awan AN, Swain CP. Endoscopic vertical band gastroplasty with an enodscopic sewing machine. Gastrointest Endosc 2002: 55: 254-256
19. Hu B, Chung SC, Sun LC et al. Transoral obesity surgery: endoluminal gastroplasty with an endoscopic suture device. Endoscopy 2005; 37: 411-414
20. Kantsevoy SV, Hu B, Jagannath SB et al. Technical feasibility of endoscopic gastric reduction: a pilot study in a porcine model. Gastrointest Endosc 2007; 65: 510-513
21. Deviere J, Ojeda Valdes G, Cuevas Herrera L et al. Safety, feasibility and weight loss after transoral gastroplasty (TOGA): first human multi-center study. Surg Endosc 2008; 22: 589-598
22. http://www.sf-36.org/
23. Kolotkin RL, Crosby RD, Kosloski KD, Williams GR. Development of a brief measure to assess quality of life in obesity. Obes Res 2001; 9: 102-111
24. Sjötröm L, Narbro Y, Sjöström CD et al. Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752
25. Nguyen NT, Wilson SE. Complications of antiobesity surgery. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 138-147
26. Voitk A, Rizoli S, Joffe J et al. Laparoscopic vertical banded gastroplasty: early results with the JOVO procedure. Obes Surg 2002; 12: 62-64
27. Egami K, Murohara T, Aoki M et al. ischemia-induced angiogenesis: role of inflammatory response mediated by P-selectin. J Leukoc Biol 2006; 79: 971-976
28. Nguyen N, Varela EJ, Nguyen T et al. Quality of life assessment in the morbidly obese. Obes Surg 2006: 16: 531-533